overview
-
Dr. Marco Pahor has demonstrated long-term academic excellence, productivity and commitment to multidisciplinary clinical translational research, team science, education and patient care. Dr. Pahor holds over 36 years of outstanding academic career and 30 years of expertise in key senior leadership roles in multicenter clinical trials and as Institute/Center director. Dr. Pahor is a nationally and internationally known thought leader in the areas of physical activity, aging, disability and function in clinical trials, population-based studies, and translational research. He has an outstanding NIH and federal funding record. He has authored or co-authored more than 434 publications in peer reviewed journals, which have resulted in over 38,000 citations. His H-Index is 100, and the i-10 index is 288 as reported in Google Scholar.
He has extensive expertise in leading multidisciplinary research teams, including multicenter clinical trials, the NIH funded Claude Pepper Older Americans Independence Center, and the University of Florida Clinical Translational Sciences Institute KL2 mentoring program. Dr. Pahor has special expertise in randomized controlled trials in older adults involving physical activity, behavioral and pharmacological interventions. He is the principal investigator and director of the Administrative Coordinating Center of The LIFE Study, a large (1,635 participants, 8 clinical sites) long-term multicenter trial to assess whether physical activity prevents major mobility disability and health related outcomes in older adults funded by the NIA. The LIFE study has demonstrated outstanding recruitment, retention and adherence yields, and timely provision of all study deliverables and benchmarks. Dr. Pahor is the field center PI of the TTrial of testosterone in older persons to assess effects on mobility, vitality and sexual function. Dr. Pahor was the PI of the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study randomized controlled trial funded by the NHLBI to assess the effect of the ACE inhibitor fosinopril on inflammatory and other biomarkers. Dr. Pahor is the PI and Director of the Administrative Coordinating Center of the ENRGISE NIA funded multicenter clinical trial to assess the effects of fish oil and losartan on systemic inflammation and mobility in older adults. He is also the MPI and Director of the Administrative Coordinating Center of MoTrPAC a multicenter consortium to assess the molecular transducers of physical activity involving 12 clinical sites enrolling 3,000 participants, 7 chemical sites, 3 animal sites and one bioinformatics site.
Dr. Pahor has a total of over 30 years of mentoring and training experience in clinical research in multidisciplinary settings, over 10 years at UF, 6 years at WFUSM, 3 years at the University of Tennessee, Memphis, and 11 years at the Catholic University in Rome, Italy. The primary focus and success of the Older Americans Independence Center he has been directing during 16 years is the career development of junior investigators. He has mentored a total of 24 pre-doctoral trainees and fellows, and 18 of his past trainees currently hold faculty and/or leadership positions.